287 related articles for article (PubMed ID: 29433461)
1. Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.
Ahorlu CSK; Koka E; Adu-Amankwah S; Otchere J; de Souza DK
BMC Public Health; 2018 Feb; 18(1):238. PubMed ID: 29433461
[TBL] [Abstract][Full Text] [Related]
2. Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.
Manyeh AK; Ibisomi L; Ramaswamy R; Baiden F; Chirwa T
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0007009. PubMed ID: 32804967
[TBL] [Abstract][Full Text] [Related]
3. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
[TBL] [Abstract][Full Text] [Related]
4. Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.
Biritwum NK; Garshong B; Alomatu B; de Souza DK; Gyapong M; Kyelem D
PLoS Negl Trop Dis; 2017 May; 11(5):e0005619. PubMed ID: 28493966
[TBL] [Abstract][Full Text] [Related]
5. Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
de Souza DK; Gass K; Otchere J; Htet YM; Asiedu O; Marfo B; Biritwum NK; Boakye DA; Ahorlu CS
PLoS Negl Trop Dis; 2020 May; 14(5):e0008306. PubMed ID: 32407319
[TBL] [Abstract][Full Text] [Related]
6. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
7. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
[TBL] [Abstract][Full Text] [Related]
8. Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana.
Biritwum NK; Yikpotey P; Marfo BK; Odoom S; Mensah EO; Asiedu O; Alomatu B; Hervie ET; Yeboah A; Ade S; Hinderaker SG; Reid A; Takarinda KC; Koudou B; Koroma JB
Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):690-695. PubMed ID: 28938053
[TBL] [Abstract][Full Text] [Related]
9. Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana.
Dicko I; Coulibaly YI; Sangaré M; Sarfo B; Nortey PA
Infect Disord Drug Targets; 2020; 20(2):167-174. PubMed ID: 30727921
[TBL] [Abstract][Full Text] [Related]
10. COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA.
Kisoka WJ; Tersbøl BP; Meyrowitsch DW; Simonsen PE; Mushi DL
J Biosoc Sci; 2016 Jan; 48(1):94-112. PubMed ID: 25790081
[TBL] [Abstract][Full Text] [Related]
11. Using intervention mapping to design and implement quality improvement strategies towards elimination of lymphatic filariasis in Northern Ghana.
Manyeh AK; Ibisomi L; Baiden F; Chirwa T; Ramaswamy R
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007267. PubMed ID: 30908495
[TBL] [Abstract][Full Text] [Related]
12. The role of gender relations in uptake of mass drug administration for lymphatic filariasis in Alor District, Indonesia.
Krentel A; Wellings K
Parasit Vectors; 2018 Mar; 11(1):179. PubMed ID: 29530082
[TBL] [Abstract][Full Text] [Related]
13. Modelling the cost of engage & treat and test & treat strategies towards the elimination of lymphatic filariasis in Ghana.
Adams NNK; Ahorlu CS; de Souza DK; Aikins M
PLoS Negl Trop Dis; 2024 May; 18(5):e0012213. PubMed ID: 38787898
[TBL] [Abstract][Full Text] [Related]
14. How community engagement strategies shape participation in mass drug administration programmes for lymphatic filariasis: The case of Luangwa District, Zambia.
Silumbwe A; Halwindi H; Zulu JM
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007861. PubMed ID: 31774820
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar.
Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ
Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891
[TBL] [Abstract][Full Text] [Related]
16. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
17. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
[TBL] [Abstract][Full Text] [Related]
18. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Nandha B; Krishnamoorthy K; Jambulingam P
Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
[TBL] [Abstract][Full Text] [Related]
19. Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities.
Biritwum NK; Frempong KK; Verver S; Odoom S; Alomatu B; Asiedu O; Kontoroupis P; Yeboah A; Hervie ET; Marfo B; Boakye DA; de Vlas SJ; Gyapong JO; Stolk WA
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007115. PubMed ID: 31398203
[TBL] [Abstract][Full Text] [Related]
20. The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
Njomo DW; Amuyunzu-Nyamongo M; Magambo JK; Njenga SM
PLoS One; 2012; 7(11):e48395. PubMed ID: 23185256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
